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Abstract 
Background: Previous studies indicate that shift work tolerance may be associated with 
individual factors including genetic variability in the gene encoding the serotonin transporter 
5-HTT (SLC6A4). The aim of the present study was to explore the interaction between work 
schedule (shift work versus non-shift work), genetic variability in SLC6A4 and insomnia 
symptoms.  
Methods: The study was based on a national probability sample survey of 987 Norwegian 
employees drawn from The Norwegian Central Employee Register by Statistics Norway. 
Insomnia symptoms were assessed by three items reflecting problems with sleep onset, sleep 
maintenance and early morning awakenings. Genotyping with regard to SLC6A4 (the 5-
HTTLPR S versus L and the SNP rs25531 A versus G) was carried out using a combination 
of gel-electrophoresis and TaqMan assay.  
Results: Using the LALA genotype as a reference a main effect of the SS genotype (B=.179; 
95% CI =.027-.330) was found. Also, a main effect of work schedule (0=non shift, 1=shift 
work) was found (B=.504; 95% CI =.185-.823). The genotype x work schedule interaction 
was significant for all genotypes; SLA (B=-.590; 95% CI =-.954--.216), LALG (B=-.879; 95% 
CI =-1.342--.415), SLG (B=-.705; 95% CI =-1.293--.117) and SS (B=-.773; 95% CI =-1.177--
.369) indicating higher insomnia symptom scores among LALA-participants compared to 
participants with other genotypes when working shifts. 
Conclusions: The ability to cope with shift work is associated with the combination of the 
SLC6A4 variants 5-HTTLPR and SNP rs25531. Our findings demonstrated that the LALA-
genotype increases the risk of insomnia symptoms among shift workers. 
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1. Introduction 
Ample evidence suggests that shift work is associated with a wide range of problems and 
disorders. These may include sick leave [1], low job satisfaction [2], turnover and turnover 
intention [3, 4], fatigue [5], sleepiness [6], gastrointestinal disorders [7], cardiovascular 
diseases [8-10], cancers (breast, colorectal, prostate) [11-14], metabolic disturbances [15-17] 
as well as psychological distress [18, 19]. The most commonly reported problem by shift 
workers, however, is sleep difficulties [20]. Sleep before morning shift, especially when 
starting the workday early, is associated with reduced sleep length and subsequent daytime 
sleepiness [20]. Moreover, daytime sleep following night work is shorter (mean 5 h 51 min) 
than sleep after evening shifts (mean 8 h 2 min) [21]. Also, sleep duration may be curtailed by 
short rest time between shift (≤ 11 hours) [22]. Still, large individual differences in terms of 
the ability to cope with shift work have been reported [23]. Evidence exists that shift work 
tolerance [24] is associated with individual factors such as age, sex, and personality [23]. In 
addition, several earlier studies suggest that shift work tolerance may be linked to genetic 
variability. 
For example, genetic polymorphisms in genes involved in circadian rhythm regulation such as 
CLOCK, NPAS2, PER2, and PER3 have been shown to be associated with outcomes such as 
alcohol/caffeine consumption and sleepiness, as well as sleep phase, inertia and duration in 
hospital day-and night-shift nurses [25]. Moreover, screening of genetic variants in clock 
genes suggests that polymorphisms in CLOCK, CRY1, NPAS3, RORA, and TEF may be 
relevant with regard to shift work disorder [26]. Previous observations also indicate that 
genetic variability of CRY1 may influence adaptation to rotating shift work [27]. 
 
The serotonin transporter 
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In addition to the clock genes mentioned above, earlier reports indicate that shift work 
tolerance could be associated with genetic variability in the gene SLC6A4 [28] encoding the 
serotonin (5-HT) transporter (5-HTT). One such genetic variant is the 5-HTT promoter 
repeated length polymorphic region (LPR) [29]. Two common allelic variants have been 
described, a short (S) allele of 14 repeats and a long (L) allele of 16 repeats [30]. The S allele 
leads to decreased 5-HTT expression [31]. In addition, there is a single nucleotide 
polymorphism (SNP) rs25531 A > G in the promoter region of SLC6A4, which also affects 
the rate of transcription [29]. This A to G substitution may only be present in the in L allele 
[32], where the G allele is associated with lower 5-HTT expression [29, 32]. Therefore, there 
is only one type of the S allele, termed S, but two types of the L alleles, termed LA and LG. 
Environmental stressors may have a more pronounced impact on individuals with the 5-HTT 
SS and SLG genotype than other individuals [33]. Workers with higher job-related stress and 
the SS genotype have increased risk of insomnia, whereas workers with low job-related stress 
and the SS genotype report reduced sleeping problems [34]. Moreover, the S allele seems to 
modulate sleep related factors such as anxiety, negative affect [35, 36], and is associated with 
an increased risk of depression and alcohol dependence [37]. In terms of sleep disorders, the S 
allele has been found to be significantly more frequent in patients suffering from insomnia 
than in controls [38], whereas the L allele has been associated with an increased risk of 
apneas/hypopneas in older subjects compared to the S-allele [39]. In males, the LL-genotype 
has been shown to be more prevalent among male obstructive sleep apnea patients than 
controls [40]. 
Interestingly, previous data indicate that rotating shift workers have an increased frequency of 
the SS genotype after 60 months of shift work exposure [41]. However, like in most previous 
studies, the participants were genotyped with regard to the S versus L allele only, not with 
regard to the SNP rs25531 A > G of SLC6A4. Thus, how shift work-related challenges such 
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as insomnia may be moderated by each of the five Caucasian 5-HTT variants; SS, SLG LALG, 
SLA and LALA [42] (LGLG is usually not found in Caucasians), remain to be investigated. 
Moreover, previous data shows that SS is associated with reduced 5-HTT expression [29, 41], 
whereas LALA seems to have the opposite effect and increase the 5-HTT expression [29, 32]. 
Thus, in particular the influence of the LALA genotype, needs to be examined. The aim of the 
present study was accordingly to examine how the 5-HTTLPR S/L and SNP rs25531 A > G 
genotype influence insomnia symptoms in shift workers. 
2 Material and methods 
2.1 Participants  
A random sample of 5000 employees was drawn from the Norwegian Central Employee 
Register by Statistics Norway, hence representing a probability sampled survey. The 
Norwegian Central Employee Register is the official register of all Norwegian employees, as 
reported by employers. Sampling criteria were adults between 18 and 60 years of age 
employed in a Norwegian enterprise. Questionnaires were distributed through the Norwegian 
Postal Service during the spring 2015. Subjects who gave consent were also sent saliva 
collection kits. Altogether, 987 subjects who had satisfactorily completed the questionnaire 
and provided a saliva sample were included in the present study. The study procedures were 
carried out in accordance with the Declaration of Helsinki and the Norwegian Health 
Research Act. The study was approved by the Regional Committee for Medical Research 
Ethics for Eastern Norway (no. REK 2014/1725). Written informed consent was provided by 
all participating respondents.  
 
2.2 Instruments 
Insomnia symptoms were assessed with three items reflecting problems with sleep onset, 
maintenance of sleep and early morning awakening, respectively. The time frame was the last 
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12 months. Response categories ranged from 1 to 4 (‘not bothered’, ‘a little bothered’, 
‘considerably bothered’, ‘seriously bothered’). The included symptoms are core nocturnal 
characteristics of insomnia, in line with modern diagnostic nosology [43, 44]. A composite 
insomnia symptoms score was calculated by adding the score of the three items and dividing 
the sum by three. The Cronbach alpha for the insomnia symptoms scale was .81 in the present 
study. The insomnia symptom items have been used in a previous study [45], still not much is 
known about their psychometric properties. Therefore, the items were validated in a sample of 
190 university students (mean age 22.0, SD= 4.6, 79% ♀) by administering, in addition, the 
Bergen Insomnia Scale [46] (BIS; higher scores indicate more insomnia symptoms), the Sleep 
Hygiene Index [47] (SHI: higher scores suggest worse sleep hygiene), and an item asking 
about lifetime use of prescribed hypnotics. The sum score of the insomnia symptom items had 
a significant and positive correlation with the composite score of the BIS (r=0.73, p<.01) and 
the SHI (r=0.22, p<.01), where the former correlation was significantly higher than the latter 
(Z=6.77, p <.01) attesting to the convergent and discriminative validity of the insomnia 
symptom items, respectively. Those with lifetime use of prescribed hypnotics scored higher 
(Mann-Whitney U = 1862, p <.05) on the insomnia symptom items (mean rank = 90.0) 
compared to those who never had used such drugs (mean rank = 113.3), thus the insomnia 
symptom items showed concurrent validity. The mean inter-item correlation of the insomnia 
items was .32, which is within the recommended range [48]. A total of 45 students 
participated in a 2-week test-retest of the insomnia symptom items which had an ICC of .79 
(p<.01) which indicates good reliability [49]. 
  
2.3 Genotyping 
Collection of saliva and extraction of genomic DNA was done using OrageneRNA sample 
collection kit (DNA Genotech Inc. Kanata, Ontario, Canada) according to the manufacturer’s 
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instructions. Genotyping with regard to SLC6A4 tandem repeat length in the promoter (short; 
S versus long; L), and genotyping with regard to the SNP rs25531 (A versus G) were 
performed. To determine the length (S versus L) of the polymorphic promoter region of 
SLC6A4, the DNA sequence was first amplified by polymerase chain reaction (PCR) and 
then separated by gel electrophoresis. PCR was carried out in a total volume of 25 µl 
containing ~60 ng of genomic template, 6.25 pmol of each primer and 1x Taq DNA 
Polymerase Master Mix (VWR international, Dublin, Ireland). The forward primer sequence 
was 5’ –GGCGT TGCCG CTCTG AATGC- 3’ and the reverse primer sequence was 5’ –
GAGGG ACTGA GCTGG ACAAC CAC- 3’ (DNA technology A/S, Risskov, Denmark). As 
previously described [32], samples were amplified on a Perkin Elmer GeneAmp PCR 2400 
system following an initial denaturing step for 3 min at 95 °C. The amplification consisted of 
40 cycles including denaturing at 95 °C for 40 s, annealing at 60 °C for 20 s and elongation at 
72 °C for 80 s. The PCR yielded a long (529 bp) and a shorter (486 bp) fragment. After four 
hours separation at 100 V on a 2.5% agarose gel (MetaPhor Agarose, Lonza cologne GmbH, 
Cologne, Germany), GelRed dye was added and the fragments were visualized by UV light 
(Biotium Inc, California, USA). A PCR 100 bp low ladder (Sigma-Aldrich CO, St. Louis, 
Mo, USA) was used to determine the length of the fragments. 
The SNP genotyping with regard to rs25531 (A versus G) was carried out using custom 
TaqMan SNP genotyping assays (Applied Biosystems, Foster City, CA, USA). 
Approximately 10 ng genomic DNA was amplified in a 5 µl reaction mixture in a 384-well 
plate containing 1x TaqMan genotyping master mix (Applied Biosystems) and 1x assay mix, 
the latter containing the respective primers and probes. The probes were labelled with the 
reporter dye FAM or VIC to distinguish between the two alleles. Approximately 10% of the 
samples were re-genotyped and the concordance rate was 100%. Due to poor quality of 47 
saliva samples the total number of respondents included in the final analysis was 940.  
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2.4 Statistical analyses 
A hierarchical regression analysis were conducted to test for associations between working 
arrangement (0=non-shift work, 1=shift work) and the length polymorphism of the serotonin 
transporter and the SNP rs25531. Educational level was included as a categorical variable 
with “secondary school or less” as the reference category. For the SLC6A4 genotypes, the 
LALA comprised the reference category. Deviation from the Hardy-Weinberg equilibrium was 
tested by the chi-squared test. In order to examine the modifying role of the SLC6A4 
genotype on the effect of work schedule on insomnia symptoms, we followed the 
recommendations for interaction analyses provided by Baron and Kenny [50]. The interaction 
analysis was conducted in two steps. Control variables, work schedule and the SLC6A4 
genotype were entered as predictors in the first step, whereas the interaction term (work 
schedule * SLC6A4) was entered in the second step. A significant interaction term and a 
significant increase in explained variance (R2) in the second step were considered as an 
interaction effect. The skewness and kurtosis values for the indicator of insomnia were within 
acceptable range for a normal distribution (between -2 and +2) [51]. Still, all analyses were 
conducted using bootstrapping (5000 resamples). Bootstrapping is a method for deriving 
robust estimates of standard error and confidence intervals for estimates such as the mean, 
median, proportion, odds ratio, correlation coefficient or regression coefficient. The bootstrap 
method has the advantage that it does not need to meet the assumptions of normality, equal 
variances, and homoscedasticity that are required in ordinary regression analyses [52]. 
Multicollinearity was not an issue in the current study as the highest noted variance inflation 
value was 4.19. All variables had a linear relationship (age) with the insomnia symptoms 
score or were categorical, hence assumptions about linearity were not violated. Statistical 
 The 5-HTTLPR rs 25531 LALA-genotype 9 
 




The mean score on the insomnia symptoms across the 940 participants was 1.68 (SD = 0.73). 
In all, 803 participants had day work, whereas 137 participants reported a work schedule 
involving some type of shift work. The overall mean age of the sample was 45.18 years (SD = 
10.05). The sample comprised 47.2% men and 52.8% females. In all 21.5% of the sample 
were smokers. In terms of highest completed education, 8.7% had secondary school or less, 
29.5% had high school, 33.4% had university/college ≤ 4 years and 28.4% had 
university/college more than 4 years. 
 
Genotype frequencies of SS, SLG, LALG, SLA and LALA were 17.7%, 7.4%, 7.3%, 42.6% and 
25.0%, respectively. No deviation from the Hardy-Weinberg equilibrium was observed. The 
characteristics of the subjects are presented in Table 1. The distribution of the five genotypes 
did not differ across work schedule (χ2=4.96, df=4, p=.293). Results from the hierarchical 
regression analyses of linear associations and interaction effects are presented in Table 2. In 
the first step, age and female gender were positively associated with insomnia symptoms, 
whereas educational level were inversely related to insomnia symptoms. The predictor 
variables explained 6.21% of the variance in insomnia symptoms. The SLC6A4 genotypes 
and work schedule were both unrelated to insomnia symptoms. The model was significant 
(Wald χ2=56.20; p<.001). 
In the second step of the analysis, the interaction term (work schedule x SLC6A4) was 
entered. In this step the SS-genotype (LALA as contrast) turned out significant and comprised 
a risk factor for insomnia symptoms. A significant work schedule x SLC6A4 interaction was 
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also observed where the genotypes SS, SLG, LALG, SLA (LALA as contrast), were associated 
with a decreased insomnia symptom score. Moreover, an increased insomnia symptom scores 
among LALA-participants when working shifts was demonstrated (see Figure 1). The 
statistical model with the interaction term explained 8.31% of the variance in insomnia 
symptoms. The model with the interaction term was also significant (Wald χ2=71.41; p<.001). 
 
4. Discussion 
The present data demonstrated a highly significant interaction between work schedule and the 
SLC6A4 genotype, reflecting higher insomnia symptom scores among LALA-participants 
compared to the other subjects when working shifts. This indicates that the LALA-genotype 
may be associated with impaired shift work tolerance. Clearly, shift workers with the LALA-
genotype reported higher levels of insomnia symptomatology than other shift workers, 
including the carriers of two S alleles. Hence, our finding fits well with previously published 
data showing a higher proportion of individuals with SS among rotating shift workers [41]. 
 
According to our data, also individuals with SLG, LALG, and SLA had relatively low insomnia 
symptom scores compared to individuals with LALA when working shifts. Thus, regarding 
sleeping problems, our results show that SS, but also the SLG, LALG, SLA subjects, adapt to 
shift work better than LALA subjects. This emphasize that examination of the association 
between shift work, variability in SLC6A4 and health outcomes should be based on combined 
5-HTTLPR S/L and SNP rs25531 A > G genotyping. The present observations suggest that 
the 5-HTTLPR S versus L, but also the SNP rs25531 A versus G, play a crucial role in terms 
of shift work tolerance and/or adaptation to novel living circumstances. The finding of the 
present study also support the idea that SLC6A4, through the serotonergic system, may be 
important for regulation of circadian rhythms. For example, earlier data show that 
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serotonergic neurons of the midbrain raphe nucleus innervates the master circadian clock, the 
suprachiasmatic nucleus (SCN) [53], probably modulating the entraining effects of light on 
the SCN pacemaker [54]. Since the LA allele is associated with higher 5-HTT expression [55], 
one hypothesis might be that the LALA-genotype is related to different 5-HT signaling and 
poorer flexibility in terms of work and sleep times. 
 
In contrast, increased frequency of the S allele has been observed in insomnia patients [38]. 
Our observation that SS non-shift workers had a higher mean insomnia symptom score than 
the LALA non-shift workers support these earlier observations. In line with this it has been 
suggested that  the S allele modulates anxiety and negative affect [35, 36]. Therefore, the S 
allele in the general population, without any stratification, may be associated with sleep 
problems. This also explains the present observation that individuals with SS overall had 
higher mean insomnia symptom score than individuals with LALA (second step in the 
regression analysis; main effect without taking into account work schedule). As 803 
participants were non-shift workers, whereas only 137 participants were shift workers, the 
effect of SS among non-shift workers seems to explain the main effect of SS on insomnia 
symptoms. Our data also support earlier findings indicating that the SS-variant, possibly 
associated with an uncoupling of the amygdala-cingulate feedback circuit implicated in the 
extinction of negative affect [56], is associated with job-related stress induced sleep problems 
[34]. Learned associations between bedroom and negative affects have been proposed at 
another important pathway for the development of insomnia [57]. Moreover, evidence exists 
that in the face of stressors, subjects with the SS-variant show stronger hypothalamus-
pituitary-adrenal cortex (HPA) axis activation that L-allele carriers [58], which resonates well 
with studies linking HPA-axis hyperactivity to sleep difficulties [59].  
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In addition, our data showed that age was positively related to insomnia symptoms which 
most likely reflects more arousals during sleep with increasing age [60], as well an increase in 
somatic conditions that may disturb sleep [61]. Women had a higher mean insomnia symptom 
score than men, which is in line with studies showing higher insomnia prevalence among 
women compared to men [62]. Educational level was inversely related to the insomnia 
symptom score and is in line with studies showing that low socioeconomic status is associated 
with insomnia [63]. The overall response rate for the questionnaire survey was 32%. This rate 
is lower than the average response rate established for survey studies [64]. Moreover, not 
more than 20% returned the saliva samples. This may have affected the results and it is for 
example known that ill-health is associated with non-response [65]. Thus, it is questionable if 
the final sample is representative for the overall population or survey pool. Still, the observed 
genotype frequencies were in accordance with previous findings [66]. Also, earlier data 
indicate that the response rate and representativity seems to have limited impact on the 
internal validity [67]. Still, given a mean age of 44-45 years, a selection bias or “healthy 
worker effect” [68] is possible. It is likely that those who do not cope well with shift work 
would either never start with such a work schedule or would leave such working arrangement 
after a short time. This may explain the finding that the shift workers in the present study 
report less insomnia symptoms than others. However, “the healthy worker effect” should 
reduce, not increase, the difference between the subjects with LALA and other shift workers. 
The association between the LALA-genotype and insomnia symptoms among shift workers 
reported here is arguably therefore not overestimated. It should be noted that despite several 
significant findings in the present study, the overall explained variance was of a relatively 
small magnitude.  
 
4.1 Conclusion  
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In conclusion, the SLC6A4 LALA-genotype significantly increases the risk of insomnia 
symptoms among shift workers. The positive relationship between the LALA-variant and 
insomnia symptoms among shift workers suggests that the LALA-genotype is associated with 
impaired shift work tolerance. Thus, future theoretical models of shift work and sleep 
(tolerance to shift work) should include genetic factors. In particular, analyses of the 
interaction between work schedule and the SLC6A4 genotype SS, SLG, LALG, SLA versus 
LALA with regard to insomnia is necessary. Importantly, the present study showed that the 
negative impact of shift work with regard to health in vulnerable subjects (individuals with 
LALA), may be more potent than previously reported. A practical implication is that 
employers, organizations, and health support should acknowledge that workers differ in their 
tolerance to shift work and that interventions directed toward shift workers should take these 
differences into consideration. 
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Table 1.  













































1.75±0.05 1.64±0.08 1.71±0.10 1.66±0.04 1.68±0.05  
Working schedulea 
 
140/26 63/7 59/10 339/61 202/33  
Age, mean±SEM  
 
45.93±0.81 43.87 44.52±1.26 45.44±0.51 44.79±0.64  
Male/female 
 
84/82 33/37 31/38 187/213 109/126  
Tobacco (n smokers) 
  
36 14 9 81 62  
Educationb 
 
13/50/59/44 9/24/23/14 11/16/18/24 29/119/138/114 20/68/76/71  
 
 
       
 
Table 2.  
Hierarchical regression with genotype LALA as reference. The analyses were adjusted for the 









95 % conf. interval 
Step 1  R2=0.0621     
 Age 0.012 0.002 0.000 0.007 – 0.016 
 Sex (0=♂, 1♀) 0.118 0.048 0.014 0.024 – 0.212 
 Tobacco1 
 
0.040 0.059 0.492 -0.075 – 0.156 
 Education2     
 High school -0.132 0.100 0.185 -0.328 – 0.064 
 University ≤4y  -0.316 0.097 0.001 -0.505 – -0.127 
 University >4y 
 
-0.329 0.098 0.001 -0.521 – -0.137 
 5-HTT     
 SLA -0.017 0.059 0.771 -0.134 – 0.099 
 LALG 0.028 0.102 0.783 -0.172 – 0.228 
 SLG  -0.045 0.094 0.635 -0.229 – 0.140 
 SS 
 
0.065 0.073 0.370 -0.078 – 0.209 
 Work schedule3  
 
-0.007 0.070 0.921 -0.144 – 0.130 
Step 2 R2=0.0831     
 Age 0.011 0.002 0.000 0.007 – 0.016 
 Sex (0=♂, 1♀) 0.124 0.048 0.009 0.031 – 0.218 
 Tobacco1 
 
0.034 0.058 0.558 -0.080 – 0.149 
 Education2     
 High school -0.140 0.099 0.161 -0.335 – 0.055 
 University ≤4y  -0.302 0.096 0.002 -0.491 – -0.113 
 University >4y 
 
-0.321 0.097 0.001 -0.512 – -0.130 
 5-HTT     
 SLA 0.066 0.061 0.281 -0.054 – 0.186 
 LALG 0.152 0.110 0.168 -0.064 – 0.369 
 SLG 0.047 0.098 0.632 -0.145 – 0.239 
 SS 
 
0.179 0.077 0.021 0.027 – 0.330 
 Work schedule3 
 
0.504 0.163 0.002 0.185 – 0.823 
 5-HTT x Work 
schedule3 
    
 SLA -0.590  0.097 0.002 -0.964 – -0.216 
 LALG -0.879 0.236 0.000 -1.342 – -0.415 
 SLG  -0.705 0.019 0.021 -1.293 – -0.117 
 SS -0.773 0.206 0.000 -1.177 – -0.369 
1non-use=0, use=1; 2secondary school or less is the reference; 3non-shift work=0, shift work=1 





       
 
Figure legend 
Figure 1. The relationship between shift work status and mean insomnia symptom score. 
Participants were divided into five groups based on SLC6A4 genotype: SS, SLG, LALG, SLA and 
LALA (used as reference for the regression analysis). Note the difference between LALG and 



























       
 
 
 
 
